News
EAACI Congress 2024, Valencia (Spain), 31 May – 03 June 2024
Together with Bencard (Germany), Inmunotek (Spain) and Leti (Germany) ClinCompetence Cologne presents 3 posters at the EACCI congress 2024 in Valencia.
in: Allergy – ARIA-EAACI Position Paper “Digitally-enabled, person-centred care (PCC) in allergen immunotherapy: An ARIA-EAACI Position Paper”
Link to the Paper on the Website of the National Library of Medicine
Together with Leti Pharma (Spain) ClinCompetence Cologne publish the data of the largest molecular study in allergic sensitization ever conducted in Germany.
Link to the Paper on the Website of the National Library of Medicine
A high-dose, depigmented polymerized birch pollen extract for subcutaneous allergen immunotherapy has a favourable efficacy/safety ratio
Oliver Pfaar1, Angelika Sager2, Ralph Mösges34, Margitta Worm5 Affiliations Department of Otorhinolaryngology, Head and Neck Surgery, Section of Rhinology and...
Together with the Imperial College London and Inmunotek, Madrid ClinCompetence Cologne present the results of a first-in-human study
Together with Sanofi, Frankfurt, Germany, ClinCompetence publishes results of a large prospective, randomized, controlled clinical trial with Ectoin Mouth and Throat Spray in patients suffering from Acute Pharyngitis and Dry Cough.
Effectiveness and Tolerability of Ectoin® Mouth and Throat Spray Althaea Honey (ERS09) for Sore Throat due to Acute Pharyngitis and Dry Cough: A Multicentre,...
September 12th, 2023 Milano:
ClinCompetence Cologne present a poster at the International Congress of the European Respiratory Society (ERS) Responder rates in patients with acute cough...
ClinCompetence contribute to a successful phase III study in grass pollen allergy published by Allergy Therapeutics PLC, Worthing, UK in the Journal “Allergy”
Short-course subcutaneous treatment with PQ Grass strongly improves symptom and medication scores in grass allergy Article DOI: 10.1111/all.15788
EAACI 2023 Hamburg, Germany: Together with Inmunotek, Madrid, Spain, ClinCompetence Cologne present the complete results of the betMan development program in birch pollen-induced rhinoconjunctivitis.
Clinical Development of Mannan conjugated birch pollen allergoids for the treatment of birch pollen allergic patients – from first-in-human to clinical validation in 3 studies
Affiliations Ralph Mösges, PhD, MD FAAAAI Esther Raskopf, PhD Silke Allekotte, PhD Mandy Cuevas, MD Enrique Fernandez-Caldas, PhD José. L. Subiza, MD, PhD...